Molecular biologist and neuroscientist, currently working at Tetraneuron, a biotechnology company focused on developing innovative gene therapies to treat neurodegenerative diseases and frailty associated with aging.
Her research focuses on the mechanisms that regulate synaptic plasticity, memory, and neuronal vulnerability, aiming to restore cognitive function and prevent neurodegeneration. She has contributed to the development of a pioneering gene therapy capable of reversing cognitive deficits and reducing neuronal degeneration in preclinical models of Alzheimer’s disease.
Dr. Sánchez-Puelles obtained her PhD in Molecular Biology from the Autonomous University of Madrid, where she conducted her doctoral research at the Centro de Biología Molecular Severo Ochoa (CBMSO, CSIC-UAM), investigating the molecular mechanisms underlying Alzheimer’s disease and Autism Spectrum Disorder. Her career combines basic and translational neuroscience, integrating molecular biology, synaptic physiology, behavior, and advanced therapies to translate scientific discoveries into real solutions that promote healthy brain aging.
